LeMaitre Vascular
LMAT
183 hedge funds and large institutions have $872M invested in LeMaitre Vascular in 2022 Q1 according to their latest regulatory filings, with 31 funds opening new positions, 62 increasing their positions, 60 reducing their positions, and 28 closing their positions.
11% more first-time investments, than exits
New positions opened: 31 | Existing positions closed: 28
3% more repeat investments, than reductions
Existing positions increased: 62 | Existing positions reduced: 60
0.77% more ownership
Funds ownership: 84.85% → 85.62% (+0.77%)
0% more funds holding
Funds holding: 183 → 183 (0)
6% less capital invested
Capital invested by funds: $928M → $872M (-$56.1M)
92% less call options, than puts
Call options by funds: $529K | Put options by funds: $6.89M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VOYA Investment Management
Atlanta,
Georgia
|
+$14.7M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$5.86M |
| 3 |
Millennium Management
New York
|
+$2.84M |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$1.86M |
| 5 |
BlackRock
New York
|
+$1.25M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Amundi
Paris,
France
|
-$3.63M |
| 2 |
State Street
Boston,
Massachusetts
|
-$1.6M |
| 3 |
Two Sigma Investments
New York
|
-$1.23M |
| 4 |
ETC
Exchange Traded Concepts
Oklahoma City,
Oklahoma
|
-$1.15M |
| 5 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
-$1.09M |
LMAT Hedge Fund Activity: Q1 2022 in Review
183 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in LeMaitre Vascular (LMAT) for Q1 2022, worth a combined $872M — down 6% from $928M a quarter earlier.
Buyers outnumbered sellers: 31 funds opened new LMAT positions and 28 closed out — a net gain of 3 holders — while 62 added to existing stakes and 60 trimmed.
The largest buyer was VOYA Investment Management, adding an estimated $14.7M. The largest seller was Amundi, cutting an estimated $3.63M.
- 183 institutional investors held LeMaitre Vascular (LMAT) as of Q1 2022, unchanged from Q4 2021.
- Funds reported $872M of LeMaitre Vascular stock for Q1 2022, down 6% quarter-over-quarter.
- 31 funds opened new LeMaitre Vascular positions in Q1 2022 and 28 closed out, a net change of +3 holders.
- The largest LeMaitre Vascular buyer in Q1 2022 was VOYA Investment Management, an estimated $14.7M added.
- The largest LeMaitre Vascular seller in Q1 2022 was Amundi, an estimated $3.63M sold.
Based on aggregated 13F filings for Q1 2022.